Glyco - OmicsDI

Show results for

Unknown (723)
Proteomics (382)
Transcriptomics (76)
Genomics (72)
Metabolomics (29)
Multiomics (3)

Organisms

Homo sapiens (247)
Bombyx mori (166)
Onchocerca volvulus (166)
Klebsiella pneumoniae (166)
Mus musculus (39)
Dermestes lardarius (7)
Senegalia senegal (7)
Frangula alnus (7)
Ceratonia siliqua (7)
Rhodotorula (7)
Oncorhynchus nerka (7)
Pandalus borealis (7)
Pachymenia carnosa (7)
Bothrops moojeni (7)
Quercus alba (7)
Megathura crenulata (7)
Sus scrofa domesticus (7)
Trypanosoma cruzi (7)
Human immunodeficiency virus 1 (7)
Gossypium hirsutum (7)
Oryctolagus cuniculus (7)
Bos taurus (7)
Gallus gallus (7)
Ovis aries (7)
Lactiplantibacillus plantarum WCFS1 (1)
Lactiplantibacillus plantarum (1)
unidentified (1)
Cricetulus griseus (1)
Rattus norvegicus (1)
Severe acute respiratory syndrome coronavirus 2 (1)

Organisms

Homo sapiens (34)
Mus musculus (19)
Cricetulus griseus (1)
Rattus norvegicus (1)

Repository

PeptideAtlas (174)
pride (166)
ENA (71)
geo (49)
biostudies-arrayexpress (35)
MetabolomicsWorkbench (24)
MassIVE (18)
iProX (9)
jPOST (8)
MetaboLights (3)
GNPS (2)

Tissue

Plasma Non-glyco (171)
Cell culture (27)
Blood plasma (16)
Blood (14)
Brain (11)
Blood serum (10)
Epithelial cell (9)
Kidney (7)
Whole body (6)
Feces (5)
Permanent cell line cell (5)
Liver (5)
Colon (5)
Cell suspension culture (4)
B cell (4)
Neutrophil (4)
Cerebrospinal fluid (3)
T cell (3)
Blood (3)
Liver (2)
Urine (2)
Adrenal medulla (2)
Blood platelet (2)
Urine (2)
Lymph node (2)
Leukocyte (2)
Cecum (1)
Cultured cells (1)
Female Reproductive System (1)
Others (1)

Disease

Colon cancer (10)
Malaria (4)
COPD (3)
Obesity (3)
Lymphoma (3)
Breast cancer (3)
Acute leukemia (3)
Cancer (2)
Diabetic nephropathy (2)
Paraganglioma (2)
Septic shock (2)
Congenital disorder of glycosylation (2)
Human immunodeficiency virus infectious disease (2)
Influenza (2)
Chronic kidney disease (2)
Disease free (2)
Irritable bowel syndrome (1)
Graft versus host disease (1)
Alzheimers disease (1)
Bacterial infection (1)
TANGO2-related metabolic encephalopathy and arrythmias (1)
Pheochromocytoma (1)
Hemolytic-uremic syndrome (1)
Hyperphosphatemic familial tumoral calcinosis (1)
Multiple sclerosis (1)
Stomach cancer (1)
Type 1 diabetes mellitus (1)
Chronic obstructive pulmonary disease (1)
Ovary epithelial cancer (1)
Liver carcinoma (1)

Technology Type

Mass Spectrometry (188)
Shotgun proteomics (102)
Bottom-up proteomics (39)
Data-dependent acquisition (34)
ESI (21)
Affinity purification coupled with mass spectrometry proteomics (10)
Glycoproteomics (8)
Gel-based experiment (7)
SRM/MRM (5)
Top-down proteomics (5)
Mass spectrometry (3)
NMR (2)
SWATH MS (2)
Unspecified (1)
All-ion fragmentation (1)
Data-independent acquisition (1)

Instrument Platform

LTQ (72)
LCQ DECA XP (26)
LTQ Orbitrap Velos (20)
TripleTOF 5600 (13)
LTQ FT (11)
QExactive (10)
LCQ Duo (9)
Q Exactive (5)
Orbitrap Fusion (4)
Orbitrap Exploris 480 (4)
Micromass Q-ToF (3)
LCQ Classic (3)
Synapt XS (2)
Orbitrap Astral (2)
Q Exactive HF (2)
Q Exactive Plus (2)
Matrix-assisted laser desorption-ionisation imaging MS - (2)
Liquid Chromatography MS - positive - reverse phase (2)
NextSeq 2000 (1)
AmaZon ETD ESI Ion Trap (Bruker) (1)
Q Exactive HF-X hybrid quadrupole-Orbitrap (1)
Agilent 1260, Velos Plus (1)
AmaZon ETD (1)
Orbitrap Fusion ETD (1)
LTQ Orbitrap XL (1)
Orbitrap Eclipse (1)
TimsTOF Pro 2 (1)
TimsTOF Pro (1)
Orbitrap Fusion Lumos (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2011 (47)
2025 (44)
2015 (34)
2026 (32)
2023 (26)
2024 (25)
2020 (21)
2022 (21)
2017 (15)
2021 (14)
2019 (12)
2010 (10)
2014 (8)
2016 (7)
2013 (6)
2018 (5)
2012 (3)
2007 (1)
2006 (1)

UNIPROT ID/AC

P02768 (159)
B4DPR2 (159)
P00450 (155)
E9PFZ2 (155)
Q8TCD0 (154)
Q6PJF2 (154)
Q6PIL8 (154)
Q6P5S8 (154)
Q5EFE6 (154)
P0C0L5 (154)
P0C0L4 (154)
P01834 (154)
A0A087X1V9 (154)
A0A087X130 (154)
A0A087WYL9 (154)
A0A087WTX5 (154)
P02765 (154)
P00738 (154)
H7C5R1 (154)
H0Y300 (154)
P00739 (153)
C9JV77 (152)
Q6GMW4 (152)
Q8NEJ1 (151)
Q8N5F4 (151)
Q8N355 (151)
Q6PIQ7 (151)
Q6IPQ0 (151)
Q6IN99 (151)
Q6GMX3 (151)

ENSEMBL ID

ENSG00000170477 (116)
ENSG00000229353 (79)
ENSG00000147251 (5)
ENSG00000247315 (4)
ENSG00000204131 (1)

CHEBI ID

CHEBI:35051 (1)
CHEBI:35072 (1)
CHEBI:35065 (1)
CHEBI:10106 (1)
CHEBI:28088 (1)

Metabolite Name

Zearalanone (1)
Zearalenone (1)
Beta-Zearalenol (1)
Alpha-Zearalenol (1)

First Public Date

2014 (32)
2025 (13)
2026 (7)
2017 (7)
2024 (5)
2020 (3)
2023 (1)
2021 (1)
2019 (1)
2012 (1)

Modification

Not available (1)

Study type

Transcription profiling by array (34)
RNA-seq of coding RNA (1)

Release Date

2025 (93)
2022 (87)
2021 (79)
2024 (78)
2023 (67)
2020 (49)
2016 (41)
2017 (39)
2018 (38)
2019 (37)
2011 (34)
2015 (25)
2014 (19)
2026 (16)
2013 (15)
2012 (13)
2010 (9)
2009 (5)
2008 (3)
2006 (3)
2007 (2)
2005 (2)
2001 (2)
2004 (1)
2000 (1)

Lab affiliation

Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne 3000, Australia (5)
Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne 3000, Australia (4)
1School of Natural Sciences, Macquarie University, Sydney, NSW, Australia 2Institute for Glyco-core Research (iGCORE), Nagoya University, Aichi, Japan (3)
IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, 1030 Vienna, Austria. (2)
BIOCEV, First Faculty of Medicine, Charles University, Czech Republic (2)
Department of Chemistry, Stanford University (2)
State Key Laboratory of Reproductive Medicine and Offspring Health, Department of Histology and Embryology, Nanjing Medical University, Nanjing, 211166, China (2)
CAS Key Laboratory of Separation Sciences for Analytical Chemistry, National Chromatographic R&A Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences (CAS), Dalian 116023, China (2)
Neuroproteomics DZNE Munich Feodor-Lynen-Str. 17 81377 Munich Germany (2)
Department of Chemistry, Stanford ChEM-H (2)
Westlake University (2)
Biological Chemistry Department, David Geffen School of Medicine, UCLA (2)
Department of Immunotechnology, Lund University (2)
University of Veterinary Medicine Vienna (2)
Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC) (1)
VU Amsterdam, Division of BioAnalytical Chemistry (1)
Copenhagen Center for Glycocalyx Research, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen N, Denmark (1)
PI The Wistar Institute, Philadelphia, PA, USA; (1)
1. School of Natural Sciences, Macquarie University, Sydney, NSW 2109, Australia 2. Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan (1)
Center for Proteomics and Metabolomics, Leiden University Medical Center, 2333 ZA, Leiden, The Netherlands (1)
Department of Biochemistry, Dorothy Crowfoot Hodgkin Building, University of Oxford, South Parks Road, OX1 3QU, UK. (1)
Max Planck Institute for Dynamics of Complex Technical Systems Magdeburg, 39106, Germany (1)
1Department of Chemistry and Sarafan Chem-H, Stanford University, Stanford, CA 94305, USA 2Howard Hughes Medical Institute, Stanford, CA 94305, USA (1)
University of Washington, Department of Biochemistry (1)
College of Life Sciences, Northwest University, Xi’an 710069, China (1)
The Rosalind Franklin Institute, Harwell Science and Innovation Campus, UK Department of Chemistry, University of Oxford, UK Department of Biochemistry, University of Oxford, UK (1)
Copenhagen Center for Glycomics (CCG), Glyco-MS Group Department of Cellular and Molecular Medicine University of Copenhagen (1)
Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany (1)
Kavli Institure for Nanoscience Discovery, Department of Chemistry, University of Oxford, Oxford, UK (1)
Associate Professor Glyco MS Group Copenhagen Center for Glycomics (CCG) Department of Cellular and Molecular Medicine University of Copenahgen Blegdamsvej 3 2200 Copenhagen N Denmark (1)

Previous page
1 / 129
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 129
Next page

Sort by:

Relevance

Page size

Human serum glycoproteome - Glyco-Decipher

Identification results of peptide-spectrum matches supporting Glyco-Decipher manuscript (Glyco-Decipher: Glycan database-independent peptide matching enables discovery of new glycans and in-depth characterization of site-specific N-glycosylation). Recently, several elegant bioinformatics tools have ...

ORGANISM(S): Homo Sapiens

PXD045630 |

Re-analysis of glycoproteomics data with MSFragger-Glyco

Reanalysis of submissions PXD011533 and PXD009476 using MSFragger-Glyco mode. Processed MSFragger results files (pepXML) and PSM tables (psm.tsv) supporting MSFragger-Glyco manuscript (Fast and Comprehensive N- and O-glycoproteomics analysis with MSFragger-Glyco. Recent advances in methods for enric...

ORGANISM(S): Mus musculus (Mouse) Homo sapiens (Human)

2020-10-06 | PXD021196 | Pride

Human serum glycoproteome - Glyco-Decipher

ORGANISM(S): Homo sapiens (Human)

2022-03-04 | PXD031025 | Pride

Glycoproteomics glycopeptide glycosylation n-glycosylation

Re-analysis of glycoproteomics data with Glyco-Decipher

Reanalysis of submissions PXD005411, PXD005413, PXD005412, PXD005553, PXD005555, PXD005565 and PXD019937 using Glyco-Decipher. Identification results of peptide-spectrum matches supporting Glyco-Decipher manuscript (Glyco-Decipher: glycan database-independent peptide matching enables discovery of ne...

ORGANISM(S): Mus musculus (Mouse) Saccharomyces cerevisiae (Baker's yeast)

2022-03-04 | PXD031032 | Pride

Glycoproteomics glycopeptide reanalysis glycosylation n-glycosylation

Functional Glyco-Nanogels for Multivalent Interaction with Lectins.

Not available

S-EPMC6572176 | biostudies-literature

Hallmarks of glyco-genes expression and their glycosylation pathways in squamous and adenocarcinoma cervical cancer

PRJNA671309 | ENA

Hallmarks of glyco-genes expression and their glycosylation pathways in squamous and adenocarcinoma cervical cancer

Dysregulation of glyco-gene expression in cancer can lead to aberrant glycans and glycoconjugates, which in turn can promote tumorigenesis. Cervical cancer display augmentation of aberrant sialylated glycans and increase of glyco-genes, which encoded enzymes participate in the sialylation pathways. ...

ORGANISM(S): Homo sapiens

2020-10-24 | GSE159976 | GEO

Antibody-lectin chimeras for glyco-immune checkpoint blockade

Despite the curative potential of checkpoint blockade immunotherapy, most patients remain unresponsive to existing treatments. Glyco-immune checkpoints – interactions of cell-surface glycans with lectin, or glycan-binding, immunoreceptors – have emerged as prominent mechanisms of immune evasion and ...

ORGANISM(S): Homo sapiens (Human)

2025-08-13 | PXD063934 | Pride

Antibody-lectin chimeras for glyco-immune checkpoint blockade

Spatial Glyco-Codes Define Human Liver Pathology and Progression

PRJNA1472674 | ENA

Glyco-gold nanoparticles: synthesis and applications.

Not available

S-EPMC5480336 | biostudies-literature

Previous page
1 / 129
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 129
Next page

Sort by:

Relevance

Page size

1282 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

ENSEMBL ID

CHEBI ID

Metabolite Name

First Public Date

Modification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets